Novavax
NVAX
#5434
Rank
โ‚ฌ1.26 B
Marketcap
7,67ย โ‚ฌ
Share price
-1.66%
Change (1 day)
27.78%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚ฌ0.43 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚ฌ1.08 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.40 B-396.87%
2024 -โ‚ฌ0.14 Billion-70.39%
2023 -โ‚ฌ0.46 Billion-16.59%
2022 -โ‚ฌ0.55 Billion-62.58%
2021 -โ‚ฌ1.47 Billion320.54%
2020 -โ‚ฌ0.35 Billion234.22%
2019 -โ‚ฌ0.11 Billion-30.17%
2018 -โ‚ฌ0.15 Billion1.69%
2017 -โ‚ฌ0.15 Billion-36.44%
2016 -โ‚ฌ0.24 Billion70.4%
2015 -โ‚ฌ0.14 Billion89.27%
2014 -โ‚ฌ71.54 Million59.83%
2013 -โ‚ฌ44.76 Million81.9%
2012 -โ‚ฌ24.61 Million50.33%
2011 -โ‚ฌ16.37 Million
2009 -โ‚ฌ32.31 Million8.8%
2008 -โ‚ฌ29.7 Million18.01%
2007 -โ‚ฌ25.16 Million18.33%
2006 -โ‚ฌ21.27 Million168.31%
2005 -โ‚ฌ7.93 Million-62.51%
2004 -โ‚ฌ21.14 Million52.4%
2003 -โ‚ฌ13.88 Million-28.21%
2002 -โ‚ฌ19.33 Million
2000 -โ‚ฌ11.02 Million177%
1999 -โ‚ฌ3.98 Million-11.54%
1998 -โ‚ฌ4.5 Million10.64%
1997 -โ‚ฌ4.07 Million-9.62%
1996 -โ‚ฌ4.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.63 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ9.15 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.67 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ8.65 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚ฌ0.61 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.25 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.85 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚ฌ7.03 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.23 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA